| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/28/2005 | EP1578363A2 Novel druggable regions in set domain proteins and methods of using the same |
| 09/28/2005 | EP1578358A2 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 09/28/2005 | EP1578356A2 Assays to monitor amyloid precursor protein processing |
| 09/28/2005 | EP1578347A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/28/2005 | EP1578345A2 Peptides and antibodies to muc 1 proteins |
| 09/28/2005 | EP1578343A2 Compositions and methods for adipose abundant protein |
| 09/28/2005 | EP1578305A2 Canine rankl and methods for preparing and using the same |
| 09/28/2005 | EP1578211A2 Kolla 2-desiccated avian sternal cartilage powder |
| 09/28/2005 | EP1578205A2 Biomarkers for intro-aminiotic inflammation |
| 09/28/2005 | EP1578197A2 Composition and method for treating lupus nephritis |
| 09/28/2005 | EP1578196A2 Mda-7 and free radicals in the treatment of cancer |
| 09/28/2005 | EP1465489A4 Methods of expressing lim mineralization protein in non-osseous cells |
| 09/28/2005 | EP1439849A4 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 09/28/2005 | EP1439846A4 Storage-stable human fibrinogen solutions |
| 09/28/2005 | EP1423695A4 Androgen receptor knock-out transgenic animals |
| 09/28/2005 | EP1402261A4 Colon cancer antigen panel |
| 09/28/2005 | EP1263787B1 G-protein coupled receptor |
| 09/28/2005 | EP1141006B1 Topoisomerase ii inhibitor |
| 09/28/2005 | EP1135486B1 RECOMBINANT SOLUBLE Fc RECEPTORS |
| 09/28/2005 | EP1129194B1 Interleukin-1 homolog zil1a4 |
| 09/28/2005 | EP1117422B1 Use of op-1 for the preparation of a pharmaceutical composition for repairing a defect locus in a non articular cartilage tissue of a mammal |
| 09/28/2005 | EP1037991B1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| 09/28/2005 | EP0991763B1 Modified adenoviral fiber and target adenoviruses |
| 09/28/2005 | EP0912743B1 Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases |
| 09/28/2005 | EP0836646B1 Ocean fish antifreeze peptides as food product additives |
| 09/28/2005 | EP0767835B1 Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family |
| 09/28/2005 | EP0743955B1 Cyclic nerve growth factor (ngf) structural analogs and their uses |
| 09/28/2005 | EP0723593B1 Use of alpha-1,4-glucan lyase for preparation of 1,5-d-anhydrofructose |
| 09/28/2005 | EP0646022B1 Prosthetic devices having enhanced osteogenic properties |
| 09/28/2005 | CN1675376A Inhibitors of inflammatory gene activity and cholesterol biosynthesis |
| 09/28/2005 | CN1675374A Treatment of liver diseases |
| 09/28/2005 | CN1675372A Use of biomarkers for detecting ovarian cancer |
| 09/28/2005 | CN1675366A Plastid genetic engineering via somatic embryogenesis |
| 09/28/2005 | CN1675363A T-cell epitopes in staphylococcal enterotoxin B |
| 09/28/2005 | CN1675362A HLA-A24-restricted cancer antigen peptide |
| 09/28/2005 | CN1675361A Genes and polypeptides relating to human colon cancers |
| 09/28/2005 | CN1675360A Genes and polypeptides relating to human colon cancers |
| 09/28/2005 | CN1675353A Substances for preventing and treating autoimmune diseases |
| 09/28/2005 | CN1675245A Monoclonal antibody hPAM4 |
| 09/28/2005 | CN1675242A T-cell epitopes in erythropoietin |
| 09/28/2005 | CN1675241A Immunogenic conjugates |
| 09/28/2005 | CN1675240A Variants of the major allergen phl p 1 from timothy grass |
| 09/28/2005 | CN1675238A Method of binding a compound to a surface |
| 09/28/2005 | CN1675237A Immunogenic compositions |
| 09/28/2005 | CN1674934A Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 09/28/2005 | CN1674933A 疫苗组合物 Vaccine compositions |
| 09/28/2005 | CN1674931A T cell receptor CDR3 sequences and methods for detection |
| 09/28/2005 | CN1674927A Growth hormone releasing peptides |
| 09/28/2005 | CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 09/28/2005 | CN1674789A Protein extraction from canola oil seed meal |
| 09/28/2005 | CN1674778A Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 09/28/2005 | CN1673376A Expression vector based on coronavirus proteolytic cleavage and its application |
| 09/28/2005 | CN1673372A A novel marnifi blue mold cell wall surface antigen II its coding sequence and application thereof |
| 09/28/2005 | CN1673371A A new marnifi blue mold cell wall surface antigen I, its coding sequence and application thereof |
| 09/28/2005 | CN1673368A HCV regulated proteins |
| 09/28/2005 | CN1673230A Prepn of recombinant composite interferon-polyglycol conjugate and conjugate product |
| 09/28/2005 | CN1220777C Nucleic acids having promoter activity and transgenic plants containing the same |
| 09/28/2005 | CN1220772C Method for separating silk gland cell of silkworm suited to researches in molecular biology |
| 09/28/2005 | CN1220705C Alpha-lipoic acid and its derivative modified insulin and preparing method thereof |
| 09/28/2005 | CN1220704C Cholalic acid derivative medified insulin and preparing method thereof |
| 09/28/2005 | CN1220703C Method for stabilising proteins in complex mixtures during thier storage in aqueous solvents |
| 09/28/2005 | CN1220702C Insulinotropic peptide and its use |
| 09/28/2005 | CN1220701C Recombinded chemotaxis cytokine of human cirumferential lymphatic tissue as well as its preparing method and use |
| 09/28/2005 | CN1220521C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/27/2005 | US6950754 Apparatus and method for automated protein design |
| 09/27/2005 | US6949695 Plant retroelements and methods related thereto |
| 09/27/2005 | US6949694 Genetic control of flowering in plants and cloning and expression of genes involved therein, in particular, cloning and expression of FY gene of Arabidopsis thaliana and manipulation and use of these genes in plants |
| 09/27/2005 | US6949691 Human albumin animal models for drug evaluation, toxicology and immunogenicity studies |
| 09/27/2005 | US6949636 Intron/exon structure of the human and mouse β3-adrenergic receptor genes |
| 09/27/2005 | US6949629 Methods for purifying selected CEA family member proteins |
| 09/27/2005 | US6949628 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection |
| 09/27/2005 | US6949627 a purified polyclonal or monoclonal antibody which recognizes an epitope of a surface protein of a merozoite of Plasmodium falciparum; capable of inducing a resistance to the parasite so it can be used as a vaccine |
| 09/27/2005 | US6949626 Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor |
| 09/27/2005 | US6949624 mediates the assembly of transcription repressor complexes by altering chromatin structure |
| 09/27/2005 | US6949623 Amplification of efficiency of gene tranfer into cells; obtain cells, icubate with genetically engineered retrovirus, transduce cells, recover transformed cells |
| 09/27/2005 | US6949513 For therapy of oral, pancreatic, colon, lung, breast or leukemia cancers |
| 09/27/2005 | US6949512 administering to patient effective amount of lipopolysaccharide binding protein to elevate serum concentration of lipopolysaccharide binding protein in patient to sufficiently high level to suppress lipopolysaccharide induced release of cytokine |
| 09/27/2005 | US6949511 Methods of inhibiting angiogenesis via increasing in vivo concentrations of kringle region fragments of plasminogen |
| 09/27/2005 | US6949506 Relaxin-like factor and methods and uses thereof |
| 09/27/2005 | US6949505 contacting neuron with a morphogen containing a dimeric protein having specific amino acid sequence : |
| 09/27/2005 | US6949380 culturing a proliferating epidermal basal cell population, exposing the cell(s) to fetuin, noggin, chordin, gremlin, follistatin, growing the cell(s) in the presence of an antisense oligonucleotide antagonist of bone morphogenetic protein (BMP) |
| 09/27/2005 | US6949378 C. elegans gro-1 gene |
| 09/27/2005 | US6949366 Complexing; purified polypeptide |
| 09/27/2005 | US6949364 An isolated DNA encoding a protein, has testicular differentiation activity |
| 09/27/2005 | US6949363 An antisense compound 8 to 30 nucleotides in length that specifically hybridizes to a nucleic acid molecule(cDNA) encoding the human leucin-rich repeat bone marrow protein or polypeptide to prevent the expression of such protein |
| 09/27/2005 | US6949362 Rhodococcus cloning and expression vectors |
| 09/27/2005 | US6949360 DNA coding for human cell surface antigen |
| 09/27/2005 | US6949359 Human IL-1 epsilon DNA and polypeptides |
| 09/27/2005 | US6949358 Human tumor necrosis factor receptor TR9 |
| 09/27/2005 | US6949357 Reagents and methods useful for detecting diseases of the urinary tract |
| 09/27/2005 | US6949356 Methods for improving secondary metabolite production in fungi |
| 09/27/2005 | US6949352 Serine-threonine phosphatase protein of a parasitic organism of the Apicomplexa phylum, applications in therapeutics |
| 09/27/2005 | US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF |
| 09/27/2005 | US6949346 Using antibody released by hybridomas cells |
| 09/27/2005 | US6949345 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 09/27/2005 | US6949337 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it |
| 09/27/2005 | US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections |
| 09/27/2005 | US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates |
| 09/27/2005 | CA2391368C Genes and methods for manipulation of growth |
| 09/27/2005 | CA2270289C Proteins with enhanced levels of essential amino acids |